Document Detail

Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation.
MedLine Citation:
PMID:  21512184     Owner:  NLM     Status:  Publisher    
BACKGROUND AND PURPOSE: Oral anticoagulants are effective at reducing stroke compared with aspirin in atrial fibrillation patients older than 75 years. Although the benefits of reduced stroke risk outweigh the risks of bleeding, the cost effectiveness of warfarin in this patient population has not yet been established. METHODS: An economic evaluation was conducted alongside a randomized, controlled trial; 973 patients ≥75 years of age with atrial fibrillation were recruited from primary care and randomly assigned to either take warfarin or aspirin. Follow-up was for a mean of 2.7 years. Costs of thrombotic and hemorrhagic events, anticoagulation clinic visits, and primary care utilization were determined. Clinical benefits were expressed in terms of a primary event avoided: fatal/nonfatal disabling stroke, intracranial hemorrhage, or systemic embolism. A cost-utility analysis was performed using quality-adjusted life years as the benefit measure. RESULTS: Total costs over 4 years were lower in the warfarin group (difference, -£165; 95% CI, -£452-£89), primarily driven by the difference in primary event costs. The primary event rate over 4 years was lower in the warfarin group (0.049 versus 0.099), and the quality-adjusted life years score was higher (difference, 0.02; 95% CI, -0.07-0.11). With lower costs and a higher quality-adjusted life years score, warfarin is the dominant treatment, but the differences in both costs and effects are small. CONCLUSIONS: Warfarin is cost-effective compared with aspirin in atrial fibrillation patients age ≥75 years. These data support the anticoagulant therapy option in this high-risk patient population. However, the small differences in costs and effects indicate the importance of exploring patient preferences.
Sue Jowett; Stirling Bryan; Jonathan Mant; Kate Fletcher; Andrea Roalfe; David Fitzmaurice; Gregory Y H Lip; F D Richard Hobbs
Related Documents :
20443754 - Efficacy of the 1064-nm q-switched nd:yag laser in melasma.
3228174 - The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: a r...
10886274 - The use of variable pulse width frequency doubled nd:yag 532 nm laser in the treatment ...
14505744 - Effects of different laser-drilled openings in the zona pellucida on hatching of in vit...
10406154 - Intraocular foreign bodies. factors influencing final visual outcome.
23792364 - The quality of vision questionnaire: subscale interchangeability.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-21
Journal Detail:
Title:  Stroke; a journal of cerebral circulation     Volume:  -     ISSN:  1524-4628     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0235266     Medline TA:  Stroke     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
From the Health Economics Unit, University of Birmingham, UK; Department of Medicine, University of British Columbia, Canada; General Practice and Primary Care Research Unit, Institute of Public Health, University of Cambridge, UK; Primary Care Clinical Sciences, University of Birmingham, UK; University Department of Medicine, City Hospital, Birmingham, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Predicting Infarction Within the Diffusion-Weighted Imaging Lesion: Does the Mean Transit Time Have ...
Next Document:  Vessel Wall Inflammation in Spontaneous Cervical Artery Dissection: A Prospective, Observational Pos...